Considering tumor histology revealed that this was likely driven by a decreased likelihood of PDX engraftment for TP53 wildtype LUAD tumors (p = 0.15, Fisher’s exact test; Supplementary Fig. 10D). The gene discussed is TP53; the disease is neoplasm.